$8.5MSeries A, 26 January 2026
Funds expand its AI-supported continuous care for GI practices after 800% patient and revenue growth in 2025.
- Amount
- $8.5M
- Stage
- Series A
- Announced
- 26 January 2026
- Lead
- ManchesterStory
- Other investors
- City Light Capital, Threshold Ventures
- Use of funds
- Funds expand its AI-supported continuous care for GI practices after 800% patient and revenue growth in 2025.
- Checked
- Amount and date matched across 2 press sources
- Sources
- Salvo Health: $8.5 Million Series A Raised To Expand Hybrid GI And Metabolic Care coverager.com
Salvo Health: $8.5 Million Series A Raised To Expand Hybrid GI And Metabolic Care pulse2.com